Eagle Strategies’s Amgen AMGN Stock Holding History

Eagle Strategies’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,548	Closed	-$440K	–	212
2024 Q1	$440K	Buy	+1,548	New	+$453K	0.1%	170

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Eagle Strategies's AMGN Position: Q2 2024 in Review

Eagle Strategies sold out of Amgen (AMGN) in Q2 2024, closing a stake of 1,548 shares — an estimated $440K sold.

Eagle Strategies first reported a position in AMGN in Q1 2024 and held it in 1 quarter. The position peaked at $440K in Q1 2024. 2,785 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.

Eagle Strategies reported no remaining Amgen position as of Q2 2024 after selling out during the quarter.
Eagle Strategies sold 1,548 Amgen shares in Q2 2024, an estimated $440K.
Eagle Strategies first reported a position in Amgen in Q1 2024 and held it in 1 quarter.
Eagle Strategies's Amgen position peaked at $440K in Q1 2024.
2,785 funds tracked by Wall St. Rank held Amgen as of Q2 2024.

Based on Eagle Strategies's 13F filing for Q2 2024, filed 8 Aug 2024.